Lawrence Ginsberg, MD, is a Houston psychiatrist and Principal Investigator with more than 40 years in clinical practice, research experience dating to 1988, and Principal Investigator leadership since 1992. At Red Oak Psychiatry Associates, Dr. Ginsberg has experience across more than 100 clinical trial protocols, including Phase 1-4 central nervous system (CNS) research involving adults, adolescents, and children.
His research experience spans major depressive disorder, treatment-resistant depression, bipolar disorder, anxiety disorders, post-traumatic stress disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, schizophrenia, substance use disorders, and related psychiatric conditions. His studies have included populations ranging from preschool-age children to older adults.
Dr. Ginsberg also brings a substantial scholarly record. His CV includes more than 100 publication and scientific-presentation entries, spanning peer-reviewed articles, abstracts, posters, and continuing medical education monographs. His work has addressed psychopharmacology, bipolar disorder, attention-deficit/hyperactivity disorder, depression, and autism and has appeared in journals including the Journal of Clinical Psychiatry, Journal of Child and Adolescent Psychopharmacology, Journal of Autism and Developmental Disorders, and Neuropsychiatric Disease and Treatment.
Dr. Ginsberg earned his medical degree from the University of Miami School of Medicine. He completed a pediatric internship through the University of Miami Affiliated Hospitals and a psychiatry residency at Baylor College of Medicine. He has served as president and chief executive officer of Red Oak Psychiatry Associates since 1991.
Dr. Ginsberg offers long-standing Principal Investigator oversight, extensive adult and pediatric CNS experience, and practice-based access to psychiatric populations in the Houston area.